Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. - Wikidata - wikimedia - TriplyDB

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

http://www.wikidata.org/entity/Q35804154

about

Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats Early detection of diabetic kidney disease: Present limitations and future perspectives Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease Clinical Predictive Factors in Diabetic Kidney Disease Progression Biomarkers in kidney fibrosis: are they useful?Biomarkers of Renal Disease and Progression in Patients with Diabetes The Prevalence and Management of Diabetic Nephropathy in Asia Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.Clinical therapeutic strategies for early stage of diabetic kidney disease.Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.A story of microalbuminuria and diabetic nephropathy Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Soluble TNF receptors and kidney dysfunction in the elderly.Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy Response to comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Diabetic nephropathy - complications and treatment.Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.Lipid biology of the podocyte--new perspectives offer new opportunities.Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.

P2860

Q21558791-8B3B7F9C-106A-4BEB-8A77-C44F518DC58E Q26741494-929CD659-232D-49EC-9C88-C29D71603233 Q26747131-2AF78D65-F33C-42B1-BF6A-E4EFC86FC844 Q26749494-7CB7878D-1DDE-4431-9A89-A40B664F8FBD Q26796625-FC9DC751-2625-48BC-82AC-88CB37BDF9DB Q26799505-6DEB8680-7B99-4C3A-866D-7C4FBEC4A00C Q26851262-A850A308-CCFB-4AB4-B01E-6F06EB13FBFC Q27347256-4C968388-B779-4BCE-9830-4ECF237A3E90 Q28080888-678B9FFA-1788-47D4-8A25-FCDE709B7B4B Q30238531-AEA75E44-BB38-49CA-99F2-E84C1B928514 Q30363683-C5C45021-FED9-4963-AAA1-1885D46E965A Q30371076-FAA0EFF1-5D8B-4A51-8455-8E29E453DBFB Q30486667-A205EF09-FE70-473D-BE55-8DB0C4AE3D73 Q33583018-728A271A-7B1F-41A2-B959-BE453848898E Q33611989-DDF05DE8-6795-4F76-812B-C1F82C269E39 Q33660677-7EA525DB-883A-45BA-9524-9ACD0F81F65B Q33672484-D388CF0A-82C1-4C21-971E-78BA414B3ADE Q33772238-C2215706-7E23-468B-9335-F4B05D6B1D9E Q34011274-3ABEDEBC-02EF-41BE-A1E3-B1533C393C91 Q34278935-48B07B15-B2A5-4795-9EE3-52C7EC34E1F5 Q34336370-3B6BBE5A-A741-44C4-B5FA-6E797F3150A7 Q34387952-6250E56A-3379-4374-912E-29D28C30F24E Q34625564-7F415BC6-59A6-4B71-9CFD-269234A4FD78 Q34634066-89C05EF0-D97A-4507-A407-761E1843A0A7 Q34682583-A4168CAE-6E6E-4E47-BE0D-7DEEA548CD00 Q34787780-DA5325E1-A0E9-4404-9180-1DAA10F4F779 Q35009712-7FC39C0B-98DA-4F49-9237-1AC9C2AC9372 Q35231318-BD0D034F-1FBE-4A48-93C5-CF1B75C140AE Q35243559-28C53586-19B4-40A4-8CF5-666AB8126E7B Q35285568-85C72306-494F-4C91-8BE6-E40CF8AC47E3 Q35364638-3A50323F-85CA-40D5-A450-3FB3CF8CA9E9 Q35474328-7D72D447-075F-4BC3-A9CA-EA47E8D39744 Q35576119-9940CFD5-771D-4087-BFAB-566D08AB4FB8 Q35630730-2793A91B-8D37-4083-A023-9A847B13D8E1 Q35652795-B6936D76-EFF5-4B19-BF6B-1F67C301FE85 Q35692544-43C4F180-EC0D-4B0C-B4D2-EF4CDFC98F8D Q35804201-8A582732-612C-4DBA-AC4D-9D245676C686 Q35817069-FF6FE9ED-5A14-4E49-8EA1-DB36537552C0 Q36039529-75A3CFE3-8A81-4A52-AA01-283AA9144789 Q36325841-74CB738E-D68F-4C7E-AE3A-81E17609E3C9

P2860

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

http://www.wikidata.org/entity/Q35804154

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@ast

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@en

type

label

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@ast

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@en

prefLabel

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@ast

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@en

P1433

Q35804154-864A0CB0-53C3-4DD0-8BD3-C57E707938AD

P1476

Q35804154-C08761C7-FCE2-4B84-8466-314E157037DD

P2093

Q35804154-0D30676E-FAB9-49D0-B345-7A9E6C721E26

Q35804154-0DA35A59-C5F5-45D8-A249-6EB915064D34

Q35804154-2886EEDA-FE50-4047-82ED-925AEEB22260

Q35804154-306A2E4D-6572-4C63-B749-9BDF5F5CBF54

Q35804154-47E2722F-E3F6-4C22-85E3-F7DD04855B3C

Q35804154-4B85B1DD-156E-4384-92AD-1C0979315A2D

Q35804154-4EF5C904-8070-441A-8E42-D5C44255728F

Q35804154-67BE79F1-44B2-4303-841D-55133A3EC4F4

Q35804154-AE7EC82D-BD35-473C-86A0-A9082653BF01

Q35804154-D104BDF9-860A-4DB6-9C22-EB378ADA57BB

P2860

Q35804154-00021A35-3243-4163-B74D-8DEA69CA8F51

Q35804154-06900322-1E6D-4AE9-9B0D-72C7D1DB9B6D

Q35804154-0821C959-AEE9-4AD4-A80E-C51742C91039

Q35804154-094126DD-59F3-4473-A28A-9F456FA562A5

Q35804154-0D2A2ADF-080D-4E3F-B8A2-DF491B234BD0

Q35804154-16CFE8C9-018C-4968-9C7F-C0CF82738323

Q35804154-26319987-6459-4171-AE76-484BAB449366

Q35804154-292030DA-EAA8-46D7-B547-FA04BCE86C59

Q35804154-6DBD0E15-1CAC-49FF-B9F8-A49BD8554864

Q35804154-6F5D3FE7-96A5-4E8F-901B-67531934894F

P304

Q35804154-265D4DAD-C514-4788-8D13-7EF114CC8544

P31

Q35804154-FA4841FA-97E7-451C-98C5-0183917D396D

P356

Q35804154-0A3C22DD-12F1-467E-83C8-B4C2E3B0D8A2

P433

Q35804154-C28B904F-EF6E-4D3B-BDDA-45E24AA4EE47

P478

Q35804154-5E448366-0B86-4206-9862-4D8206F0E783

P50

Q35804154-9B7E00FB-C399-4511-99A0-894B029F98D9

P577

Q35804154-BA3C3C72-F387-48D8-882E-C3B868B45CCA

P698

Q35804154-6211194A-9ECE-4734-8931-EBDB7DE7E2AE

P921

Q35804154-84256E37-F043-444E-A972-D2D88EAF5C2A

Q35804154-B3423EE9-D286-4ED6-B798-C0CCAFF14FD8

P932

Q35804154-5BFFD88F-E007-4AB3-A32C-708D2E8088E0

P356

P1433

Journal of the American Society of Nephrology

P1476

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

@en

P2093

Adam M Smiles

http://www.w3.org/2001/XMLSchema#string

Amanda C Johnson

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Florencia Rosetti

http://www.w3.org/2001/XMLSchema#string

Gordon Crabtree

http://www.w3.org/2001/XMLSchema#string

James H Warram

http://www.w3.org/2001/XMLSchema#string

Jan Skupien

http://www.w3.org/2001/XMLSchema#string

Monika A Niewczas

http://www.w3.org/2001/XMLSchema#string

Tanya N Mayadas

http://www.w3.org/2001/XMLSchema#string

Tomohito Gohda

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of a receptor for human tumor necrosis factor

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

The ADAM metalloproteinases

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up

Role of immunocompetent cells in nonimmune renal diseases.

Renal and retinal effects of enalapril and losartan in type 1 diabetes

Cystatin C identifies chronic kidney disease patients at higher risk for complications.

TNF receptor subtype signalling: differences and cellular consequences.

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

P304

516-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2011060628

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Linda H Ficociello

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22266664

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3294299

http://www.w3.org/2001/XMLSchema#string